Hepatic Stellate Cell Differentiation Protocol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing hepatic stellate cells and hepatic sinusoidal endothelial cells quickly lead to de-differentiation and activation, losing their functional attributes, and there is a lack of a renewable source of quiescent hepatic stellate cells necessary for anti-liver fibrosis therapies.
Innovation Solution
A method involving a four-step differentiation protocol using specific concentrations of Wnt3a, ActivinA, bFGF, BMP4, aFGF, FGF4, FGF8b, HGF, and Follistatin to induce cells into hepatic stellate and sinusoidal endothelial phenotypes, maintaining their functional characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If cells are cultured to expand hepatic stellate cells and sinusoidal endothelial cells, then cell availability increases, but the cells rapidly de-differentiate and activate, losing their functional attributes
Solution Approach 1:
The patent applies preliminary action by establishing a differentiated cell population before it undergoes de-differentiation. The method involves differentiating hepatoblasts into hepatic stellate cells and sinusoidal endothelial cells, then immediately isolating and preserving them in a differentiated state, preventing the harmful de-differentiation process from occurring in the first place
Solution Approach 2:
The patent extracts the differentiated cell population from the culture at the optimal time before de-differentiation occurs. By isolating the cells at the peak of their differentiated state and preserving them separately, the method removes these cells from the harmful cultural environment that would cause de-differentiation, thereby maintaining their functional attributes
2Productivity
If conventional culture methods are used to maintain hepatic stellate cells, then cells can be expanded, but they quickly acquire activated phenotype and lose quiescent characteristics
Solution Approach 1:
The patent applies preliminary action by establishing the differentiated phenotype before expansion occurs. The method differentiates hepatoblasts into the desired cell types first, then expands these pre-differentiated cells under controlled conditions, ensuring the phenotype is established before any expansion takes place
Solution Approach 2:
The patent employs parameter changes by carefully controlling culture conditions including growth factors, cytokines, and environmental parameters to maintain phenotype stability during expansion. The method uses specific combinations of Wnt3a, ActivinA, bFGF, BMP4, and other factors to preserve the differentiated state while allowing cell proliferation
3Quantity of substance
If there is a shortage of quiescent hepatic stellate cells, then anti-liver fibrosis therapies are limited, but isolating these cells from normal livers is difficult and non-renewable
Solution Approach 1:
The patent creates a renewable copy of quiescent hepatic stellate cells through in vitro differentiation. Instead of relying on rare isolated cells from normal livers, the method generates multiple copies by differentiating hepatoblasts in culture, creating an unlimited renewable source that replicates the desired cell characteristics
Solution Approach 2:
The patent applies preliminary action by establishing the differentiated cell population before it undergoes de-differentiation. The method involves differentiating hepatoblasts into hepatic stellate cells and sinusoidal endothelial cells, then immediately isolating and preserving them in a differentiated state, preventing the harmful de-differentiation process from occurring in the first place
Data Source
AI summary
The invention is directed to methods for culturing cells so that the cells are induced to differentiate into cells that express a hepatic stellate phenotype and cells that express a hepatic sinusoidal endothelial phenotype. The invention is also directed to cells produced by the methods of the invention. The cells are useful, among other things, for treatment of liver deficiency, liver metabolism studies, and liver toxicity studies.